Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
D000954:Antigens, Surface / Q000032:analysis*; D001402:B-Lymphocytes / Q000473:pathology; D001853:Bone Marrow / Q000201:enzymology; D003114:Colony-Forming Units Assay; D004253:DNA Nucleotidylexotransferase / Q000378:metabolism*; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D003937:Diagnosis, Differential; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000503:physiopathology*; D008223:Lymphoma / Q000175:diagnosis / Q000503:physiopathology*; D011379:Prognosis; D013601:T-Lymphocytes / Q000473:pathology
D000954:Antigens, Surface; D004254:DNA Nucleotidyltransferases; D004253:DNA Nucleotidylexotransferase